Comments on ‘The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers’

Documenti analoghi

• Antimicrobial resistance is not increasing in subsequent cases of ischaemic foot infections, a single‐centre cohort from 2012 to 2021
  di: Mostafa Javanian, et al.
  Pubblicazione: (2024)
• Commentary on “The infected diabetic foot: Incidence and risk factors for dehiscence after surgery for diabetic foot infections”
  di: Majid Khalilizad, et al.
  Pubblicazione: (2025)
• RETRACTED: The impact of inflammatory biomarkers on amputation rates in patients with diabetic foot ulcers
  di: Yun Xu, et al.
  Pubblicazione: (2024)
• Commentary on “Polymicrobial Infection in Bone Biopsies and Relapse in Diabetic Foot Osteomyelitis: The Role of Soft Tissue Involvement”
  di: Mostafa Javanian, et al.
  Pubblicazione: (2025)
• Commentary on “Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real‐world data from the German/Austrian DPV registry”
  di: Mostafa Javanian, et al.
  Pubblicazione: (2024)